ClinicalTrials.gg
Not yet recruitingNCT07849322Updated Sep 30, 2026

Effects of Video LMA Cuff Pressure in Tympanoplasty.

An observational study in Oropharyngeal Leak Pressure, Airway Management and Postoperative Sore Throat, Cough, Hoarseness, sponsored by Samsun University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-30.

Sponsored by Samsun University · Observational

How we know

Updated Sep 30, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
48
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Cough with a site in Turkey — 8 open to participants now, 8 under way, none of them phase 3. Cough · Turkey.

Planned enrollment
5th of 10
48 · median 46
Started
2026
with 4 others
Observational
10 of 21
5 open now
Registered
20th of 21
by date

Among the 21 studies in Cough with a site in Turkey, this one is the 5th largest by planned enrollment of the 10 observational ones that give a count, is one of 5 that started in 2026, is one of 10 observational ones, and was the 20th registered.

Cough

429 studies on the registry are indexed under Cough; 68 are open to participants now.

Browse Cough studies →

Open to participants now

8 of the 21 studies in Cough with a site in Turkey are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 45 Cough studies recruiting now, 20 (44%) set no upper age limit and 14 (31%) stop at 75 or younger; 10 take children under 18; 6 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Cough with a site in Turkey, or all of them as a file.
02

Study summary

This prospective observational study aims to evaluate the effects of different cuff pressure levels of the Video Laryngeal Mask Airway (Video LMA) on airway safety, ventilation efficacy, and postoperative pharyngeal symptoms in patients undergoing tympanoplasty surgery. Patients are evaluated in two groups based on the measured Video LMA cuff pressure: 50 cm H2O or lower, and higher than 50 cm H2O. The primary outcome is oropharyngeal leak pressure (OLP). Secondary outcomes include the incidence and severity of postoperative pharyngeal symptoms, such as sore throat, dysphagia, and hoarseness, assessed during the first 24 hours postoperatively. Video LMA provides visual confirmation of correct anatomical position, allowing the effects of cuff pressure to be evaluated independently of device malposition.

03

Conditions studied

  • Oropharyngeal Leak Pressure
  • Airway Management
  • Postoperative Sore Throat, Cough, Hoarseness

Browse trials for

Keywords

  • Cuff Pressure
  • Video Laryngeal Mask Airway
  • Oropharyngeal Leak Pressure
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients scheduled to undergo elective tympanoplasty surgery under general anesthesia requiring supraglottic airway management with a Video LMA.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for elective tympanoplasty under general anesthesia
  • (ASA) physical status I-II-III
  • Aged between 18 and 75 years
  • Written obtained prior to surgery

Exclusion criteria

Exclusion Criteria:

  • Patients who refuse to participate in the study
  • Illiterate patients
  • Patients unsuitable for laryngeal mask airway ventilation
  • Patients with preoperative sore throat
  • Patients who used NSAIDs within 24 hours prior to surgery
  • Patients diagnosed with gastroesophageal reflux
  • Patients with a history of oropharyngeal and/or head and neck surgery
  • Patients with IV
  • Patients with cognitive impairment or unable to cooperate
  • Patients diagnosed with psychiatric disorders (schizophrenia, mania, depression, etc.)
  • Patients using antipsychotic medication for longer than 4 weeks
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
48 participants (estimated)
Patient registry
No

Groups and cohorts

  • Video LMA Cuff Pressure <= 50 cm H2O

    Patients undergoing tympanoplasty under general anesthesia in whom the Video LMA cuff pressure is measured at 50 cm H2O or lower. Oropharyngeal leak pressure is measured intraoperatively after visual confirmation of device position, and postoperative pharyngeal symptoms are monitored for the first 24 hours.

  • Video LMA Cuff Pressure > 50 cm H2O

    Patients undergoing tympanoplasty under general anesthesia in whom the Video LMA cuff pressure is measured higher than 50 cm H2O. Oropharyngeal leak pressure is measured intraoperatively after visual confirmation of device position, and postoperative pharyngeal symptoms are monitored for the first 24 hours.

06

What researchers measure

Primary outcomes

  1. Oropharyngeal Leak Pressure

    Oropharyngeal leak pressure (OLP) is measured in cm H2O after confirming proper Video LMA placement. With a fresh gas flow set at 6-8 L/min, the expiratory (APL) valve is gradually closed, and OLP is recorded as the airway pressure at which an audible air leak is detected.

    Time frame: Intraoperatively

Secondary outcomes

  1. Postoperative Sore Throat

    The incidence and severity of postoperative sore throat reported by patients. Assessed using a standard 4-point scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe

    Time frame: Up to 24 hours postoperatively

  2. Postoperative Dysphagia and Hoarseness

    The presence and incidence of swallowing difficulty (dysphagia) and voice alteration (hoarseness) reported by patients.

    Time frame: Up to 24 hours postoperatively

07

Study locations

1 site
08

References and documents

Publications

  • Gomez-Rios MA, Lopez T, Sastre JA, Gaszynski T, Van Zundert AAJ. Video laryngeal masks in airway management. Expert Rev Med Devices. 2022 Nov;19(11):847-858. doi: 10.1080/17434440.2022.2142558. Epub 2022 Nov 8. PubMed 36308748 ↗
  • Ramachandran SK, Kumar AM. Supraglottic airway devices. Respir Care. 2014 Jun;59(6):920-31; discussion 931-2. doi: 10.4187/respcare.02976. PubMed 24891199 ↗
  • 1) Machado, H. (2016). Supraglottic Airway Devices: A Review in a New Era of Airway Management. Journal of Anesthesia Clinical Research. https://doi.org/10.4172/2155-6148.1000647

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Jan 2027, 3 months later.

Of 33 observational studies under Cough, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 14. This study's planned 3 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 24, 2026
First posted
Sep 30, 2026
StartEst.
Sep 25, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Feb 1, 2027
Last update
Sep 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 30, 2026
Show all 1 update
  1. Sep 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07849322
Lead sponsor
Samsun University
Responsible party
Sponsor
First posted
Sep 30, 2026
Start date
Sep 25, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Sep 30, 2026

Study contacts

R.Burak Ferli, MD
Contact
rburakferli.md@gmail.com
+90 542 645 92 95

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion